tiprankstipranks
Advertisement
Advertisement

Chaoju Eye Care Sets 2026 AGM to Approve Dividend, Board Mandates and Share Issue Authority

Story Highlights
  • Chaoju Eye Care will hold its 2026 AGM to approve 2025 results and a HK$0.2423 dividend.
  • Shareholders will vote on director re-elections, auditor renewal and a 20% share issuance mandate.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Chaoju Eye Care Sets 2026 AGM to Approve Dividend, Board Mandates and Share Issue Authority

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Chaoju Eye Care Holdings Ltd. ( (HK:2219) ).

Chaoju Eye Care Holdings Limited has called its annual general meeting for May 12, 2026 in Beijing, where shareholders will review the audited financial statements for the year ended December 31, 2025 and vote on a proposed final dividend of HK$0.2423 per share. The AGM agenda also includes the re-election of two executive directors and two independent non-executive directors, the authorization of director remuneration, the re-appointment of Ernst & Young as auditor, and a general mandate allowing the board to issue up to 20 per cent of the company’s share capital, moves that collectively shape the company’s governance, capital-raising flexibility, and shareholder returns for the coming year.

More about Chaoju Eye Care Holdings Ltd.

Chaoju Eye Care Holdings Limited is a China-based ophthalmic medical services provider listed in Hong Kong. The company operates eye care hospitals and clinics, offering diagnosis, treatment, and surgical services focused on ophthalmology and vision correction to patients across its network.

Average Trading Volume: 448,086

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.01B

See more data about 2219 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1